Related Experiment Video
Updated: Jun 21, 2026
06:25
Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Targeting the IGF1 axis in cancer proliferation
Ilan Bruchim1, Zohar Attias, Haim Werner
1Tel Aviv University, Sackler School of Medicine, Department of Human Molecular Genetics and Biochemistry, Tel Aviv, Israel.
Expert Opinion on Therapeutic Targets
|August 12, 2009
Summary
The Insulin-like Growth Factor 1 Receptor (IGF1R) is crucial in cancer biology. Targeting IGF1R shows promise for treating cancers linked to the IGF system.
Area of Science:
- Molecular Biology
- Cancer Research
- Endocrinology
Background:
- The Insulin-like Growth Factor (IGF) system regulates growth, differentiation, and metabolism.
- Dysregulation of the IGF system is implicated in pathologies, including cancer.
- The IGF1 receptor (IGF1R) is a key component of this signaling network.
Purpose of the Study:
- To analyze the role of IGF1R in cancer biology.
- To explore interactions between IGF signaling pathways and cancer genes.
- To review malignancies involving the IGF system and IGF1R-targeted therapies.
Main Methods:
- Literature review of IGF1R function in cancer.
- Analysis of IGF signaling pathway interactions with oncogenes and tumor suppressors.
- Summary of preclinical and clinical studies on IGF1R-targeted modalities.
Main Results:
- IGF1R plays a significant role in cancer development and progression.
- Specific IGF1R targeting has yielded promising experimental and clinical outcomes.
- The IGF system is involved in various malignancies, making it a therapeutic target.
Conclusions:
- IGF1R is a critical mediator in cancer biology.
- Targeting IGF1R represents a promising therapeutic strategy for IGF system-associated cancers.
- Further research into IGF1R-targeted therapies is warranted for clinical application.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...